Research trend of albumin-bound paclitaxel for the treatment of lung cancer: A 20-year investigation

Research trend of albumin-bound paclitaxel for the treatment of lung cancer: A 20-year investigation

Bibliographic Details
Main Authors:	Lei Wang, Gang Zhao, Hong Fang, Pengcheng Deng
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Asian Journal of Surgery
Subjects:	Primary lung cancer Paclitaxel Bibliometric analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958424000320

Similar Items

Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023-09-01)

Peripheral neurotoxicity induced by albumin-bound paclitaxel: a case report
by: Xiaojing Li, et al.
Published: (2024-09-01)

Albumin-Bound Paclitaxel: Worthy of Further Study in Sarcomas
by: Zhichao Tian, et al.
Published: (2022-02-01)

Clinical Research on Albumin-bound Paclitaxel-based Therapy in Advanced Lung Cancer
by: Xu LI, et al.
Published: (2017-06-01)

MRI-guided microwave ablation and albumin-bound paclitaxel for lung tumors: Initial experience
by: Xiaokang Shen, et al.
Published: (2022-11-01)

Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

Evaluate the Clinical Outcome of Nanoparticle Albumin-bound Paclitaxel on Breast Cancer Treatment: A Systematic Review and Meta-analysis
by: Yasaman Shariati, et al.
Published: (2022-09-01)

Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema
by: Junhyuck Lee, et al.
Published: (2019-01-01)

Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients
by: Qingmei Li, et al.
Published: (2018-11-01)

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer
by: Yuki Nakatani, et al.
Published: (2017-08-01)

Effects of paclitaxel and gefitinib on the proliferation and cell cycle of human lung adenocarcinoma cell SPC-A1
by: Gang JIA, et al.
Published: (2008-06-01)

A case report of hypocalcemia after chemotherapy with albumin‐bound paclitaxel
by: Zhongchao Wang, et al.
Published: (2023-03-01)

Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma
by: Zhichao Tian, et al.
Published: (2020-07-01)

Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration
by: Yoontaek Lee, et al.
Published: (2024-06-01)

Weekly Paclitaxel and Cisplatin in the Treatment of Elderly Advanced Non-small Cell Lung Cancer
by: Ying LIANG, et al.
Published: (2009-10-01)

Efficacy and safety of camrelizumab combined with albumin-bound paclitaxel as third- or later-line regimen in patients with advanced non-small cell lung cancer
by: Jianfeng Zhu, et al.
Published: (2023-12-01)

Intravitreal Ranibizumab Had Limited Effect on Cystoid Macular Edema Due to Albumin-Bound Paclitaxel: A Case Report and Literature Review
by: Suna Ye, et al.
Published: (2021-12-01)

Formulation and evaluation of cetuximab functionalized phospholipid modified nanocrystals of paclitaxel for non-small cell lung cancer therapy
by: Manish Kumar, et al.
Published: (2024-11-01)

A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
by: Hisashi Tanaka, et al.
Published: (2017-10-01)

Efficacy and safety of albumin-bound paclitaxel combined with gemcitabine in the treatment of advanced and metastatic pancreatic cancer
by: TIAN Yue, et al.
Published: (2023-09-01)

Nanoparticle Albumin-Bound Paclitaxel- and/or Gemcitabine-Induced Scleroderma Accompanied by Acanthosis Nigricans-Like Skin Changes
by: Sei-ichiro Motegi, et al.
Published: (2019-10-01)

Nimotuzumab Significantly Enhances Chemosensitivity of PC9 Human Lung Adenocarcinoma Cells to Paclitaxel in vitro
by: Yu XIAO, et al.
Published: (2015-02-01)

Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment
by: Wing-Hin Lee, et al.
Published: (2020-12-01)

Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives
by: Zhichao Tian, et al.
Published: (2024-02-01)

A Radomized Clinical Trial on the Clinical Efficacy and Toxicities of Single-agent Paclitaxel Liposome versus Paclitaxel Liposome plus Oxaliplatin as First-line  Chemotherapy for Advanced Non-small Cell Lung Cancer in Elderly Patients
by: Xiaomei ZENG, et al.
Published: (2012-02-01)

Cystoid Macular Edema following Treatment with Nanoparticle Albumin-Bound Paclitaxel and Atezolizumab for Metastatic Breast Cancer
by: Hiroaki Yamane, et al.
Published: (2023-10-01)

Research Progresses of Albumin-bound Paclitaxel in the Treatment of Non-small Cell Lung Cancer
by: Peng LI, et al.
Published: (2010-07-01)

Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
by: Amirhosein Maharati, et al.
Published: (2023-07-01)

Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer
by: Wei Zheng, et al.
Published: (2023-06-01)

Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer: In vitro and in vivo investigation
by: Mao Li, et al.
Published: (2024-05-01)

The Clinical Analysis of Paclitaxel at Two Dose Levels plus Carboplatin as the First-line Treatment in Advanced Non-small Cell Lung Cancer
by: Jialin QIAN, et al.
Published: (2011-04-01)

Paclitaxel-induced acute fibrinous and organizing pneumonitis in early breast cancer: A case report
by: Piyarat Limpawittayakul, et al.
Published: (2024-01-01)

Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity
by: Yan D, et al.
Published: (2025-02-01)

Efficacy and safety of nanoparticle albumin-bound paclitaxel in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials and observational studies
by: Nittiya Suwannasom, et al.
Published: (2023-11-01)

Clinical Efficacy of Liposomal Paclitaxel in Maintenance Treatment of Patients with Advanced Squamous Cell Lung Carcinoma
by: SHAO Jianghe, et al.
Published: (2018-08-01)

Evaluation of nanoparticle albumin-bound paclitaxel loaded macrophages for glioblastoma treatment based on a microfluidic chip
by: Zuorun Xie, et al.
Published: (2024-03-01)

Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
by: Huan Wang, et al.
Published: (2022-06-01)

Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo
by: Zhao X, et al.
Published: (2019-02-01)

Suppression of the LKB1-AMPK-SLC7A11-GSH signaling pathway sensitizes NSCLC to albumin-bound paclitaxel via oxidative stress
by: Dade Rong, et al.
Published: (2025-04-01)

Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
by: Shanqiang Qu, et al.
Published: (2023-10-01)